Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore

NCT04339075 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-11-02

No results posted yet for this study

Summary

To assess the efficacy of the Venablock©Vein Sealing System (VBVS) for the treatment of lower extremity superficial truncal veins in a real-world clinical setting in a multi-racial Asian population in Singapore.

Conditions

  • Varicose Veins
  • Venous Reflux
  • Chronic Venous Insufficiency

Interventions

OTHER

Questionnaires

Questionnaires to access the quality of life (EQ5D, VCSS, CVVQ, CIVIQ, Patient satisfaction survey)

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Turn Yip Tang · Singapore General Hospital

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-10-01
Completion
2021-10-01

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04339075 on ClinicalTrials.gov